(NASDAQ: COEP) Coeptis Therapeutics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 75.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.64%.
Coeptis Therapeutics Holdings's earnings in 2025 is -$11,279,683.On average, 3 Wall Street analysts forecast COEP's earnings for 2025 to be -$925,975, with the lowest COEP earnings forecast at -$889,662, and the highest COEP earnings forecast at -$953,210. On average, 3 Wall Street analysts forecast COEP's earnings for 2026 to be -$925,975, with the lowest COEP earnings forecast at -$889,662, and the highest COEP earnings forecast at -$953,210.
In 2027, COEP is forecast to generate -$980,444 in earnings, with the lowest earnings forecast at -$941,996 and the highest earnings forecast at -$1,009,281.